Skip to main content
. 2015 Nov 20;5:256. doi: 10.3389/fonc.2015.00256

Table 2.

Mean (±1 SD) total and tumor sub-volume TCP values (upper rows) and NTCP values of the evaluated models (lower rows) for the two DE levels and both treatment modalities.

IMXT IMPT

TCPDE1/% TCPDE2/% TCPDE1/% TCPDE2/%
Total 66.3 ± 0.9 75.9 ± 1.3 65.5 ± 0.8 74.8 ± 1.3
GTVSIB 73.7 ± 0.8 83.2 ± 1.2 73.5 ± 0.9 83.1 ± 1.2
CTVgross 92.2 ± 0.6 93.3 ± 1.0 91.7 ± 0.5 92.7 ± 1.0
CTVelec 97.7 ± 0.4 97.7 ± 0.4 97.1 ± 0.5 97.1 ± 0.5

NTCPDE1/% NTCPDE2/% NTCPDE1/% NTCPDE2/%

Oral mucositis 45.8 ± 9.0 46.2 ± 9.2 40.0 ± 12.4 40.2 ± 12.5
Xerostomia 20.5 ± 10.9 20.6 ± 11.2 6.7 ± 4.6 6.7 ± 4.6
Aspiration 57.5 ± 23.2 65.8 ± 23.4 37.5 ± 25.1 43.8 ± 26.8
Dysphagiaa 47.5 ± 11.4 49.5 ± 11.9 36.7 ± 13.1 37.7 ± 13.5
Swall. Solidsb 34.4 ± 9.7 36.6 ± 10.5 25.7 ± 10.9 26.6 ± 11.4
Swall. Liquidsb 10.3 ± 4.4 11.4 ± 5.2 9.0 ± 4.7 9.5 ± 5.1
Larynx edema 77.8 ± 25.0 79.0 ± 24.9 64.6 ± 36.9 65.4 ± 37.0
Trismus 30.9 ± 5.7 31.0 ± 5.8 26.0 ± 3.7 26.0 ± 3.8

aPhysician-rated swallowing dysfunction.

bPatient-rated swallowing problems of different severity.